ETON PHARMACEUTICALS, INC.

ETON NASDAQ
6.48
-0.07
-1.07%
Opening 11:59 07/23 EDT
Open
6.52
Prev Close
6.55
High
6.52
Low
6.48
Volume
1.30K
Avg Vol (3M)
62.86K
52 Week High
10.20
52 Week Low
5.70
% Turnover
0.01%
Market Cap
105.74M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers ETON PHARMACEUTICALS, INC. ETON stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Eton Pharmaceuticals, Inc. is a is a specialty pharmaceutical company, which is focused on developing and commercializing pharmaceutical products. It products include EM-100, ET-103, CT-100, DS-300, DS-200, and DS-100. The Company focuses on product candidates that are liquid in formulation, including injections, oral liquids and ophthalmics. EM-100 is an ophthalmic product with a preservative-free formulation of the active ingredient ketotifen, and is indicated for the treatment of allergic conjunctivitis. ET-103 is an oral liquid formulation of levothyroxine, which is widely used in tablet and capsule form, and is indicated for the treatment of hypothyroidism. CT-100 is our patent-pending synthetic corticotropin therapeutic candidate that mimics the amino acid chain of injectable product H.P. Acthar Gel. DS-300 is a patent-pending injectable product candidate indicated to treat nutritional deficiencies. DS-200 is an injectable product candidate indicated to treat pain management.
MORE >

Recently

Name
Price
%Change